Abstract

Purpose: To develop a highly sensitive and specific ultra-performance liquid chromatography with linear ion trap Orbitrap mass spectrometer (UPLC-LTQ-Orbitrap) method to profile and identify the metabolites of evodiamine in rats. Methods: First, blood samples were collected after oral administration of evodiamine to rats (50 mg/kg). Next, the plasma samples were pretreated using a solid-phase extraction (SPE) method. Finally, all the samples were analyzed by ultra-performance liquid chromatography LTQ-Orbitrap mass spectrometry (UPLC-LTQ-Orbitrap) coupled with electrospray ionization source (ESI) in negative mode. Results: A total of 7 metabolites (2 phase I and 4 phase II metabolites, including 4 new metabolites, viz, 10-hydroxyevodiamine sulfate, 10-hydroxyevodiamine sulfate, 10-hydroxyevodiamine glucuronide and 3-hydroxyevodiamine glucuronide) as well as the parent drug itself , were detected and identified based on accurate mass measurements, fragmentation patterns, and chromatographic retention times. The in vivo metabolic reactions of evodiamine in rats were hydroxylation, hydroxylation + sulfate conjugation, and hydroxylation + glucuronidation. Conclusion: These results provide better understanding of the metabolism of evodiamine as well as strong indications of the effective forms of the drug in vivo.

Highlights

  • Evodiamine belonging to indoloquinazoline alkaloids, is a major constituent isolated from the herbal medicine Evodia rutaecarpa (Wu-zhu-yu), which has been officially listed in Chinese Pharmacopoeia [1] and widely used in China for more than 2000 years

  • In order to facilitate the structural identification of the metabolite, the MSn fragmentation pattern of evodiamine was investigated [17]

  • Fragmentation of the parent ion provided characteristic fragment ions at m/z 169.0765 (2.5 ppm, C11H9N2) and m/z 142.0658 (4.7 ppm, C10H9N) by the loss of the moieties C8H7ON and Metabolites M1 and M2 were eluted at 17.42 and 19.29 min with the quasi-molecular ions of m/z 318.1248 (3.6 ppm, C19H16O2N3) and m/z 318.1245 (2.6 ppm, C19H16O2N3), 16 Da more than that of evodiamine, indicating that it might be the product of mono-hydroxylated of the prototype drug

Read more

Summary

INTRODUCTION

Evodiamine belonging to indoloquinazoline alkaloids, is a major constituent isolated from the herbal medicine Evodia rutaecarpa (Wu-zhu-yu), which has been officially listed in Chinese Pharmacopoeia [1] and widely used in China for more than 2000 years. The chemical formulas for all parent ions of the selected peaks were calculated from the accurate mass using a formula predictor by setting the parameters as follows: C [0 – 30], H [0 – 50], O [0 – 20], S [0 – 4], N [0 – 4], Cl [0 – 4], and ring double bond (RDB) equivalent value [0 – 15]. Other elements such as P and Br were not considered because they are rarely present in the complex matrix

RESULTS
DISCUSSION
CONCLUSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call